Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001255294-12-000652
Filing Date
2012-09-05
Accepted
2012-09-05 16:11:34
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q/A 20103
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 19490
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8028
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 8010
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5768
6 EXHIBIT 99.1 ex99_1.htm EX-99.1 77575
  Complete submission text file 0001255294-12-000652.txt   3461920

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ambse-20120630.xml EX-101.INS 626269
8 XBRL SCHEMA FILE ambse-20120630.xsd EX-101.SCH 59014
9 XBRL DEFINITION FILE ambse-20120630_def.xml EX-101.DEF 75727
10 XBRL LABEL FILE ambse-20120630_lab.xml EX-101.LAB 216580
11 XBRL PRESENTATION FILE ambse-20120630_pre.xml EX-101.PRE 171739
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus BioSciences, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-148922 | Film No.: 121074102
SIC: 2834 Pharmaceutical Preparations